Lunsumio intravenous drip 1mg (Mosunetuzumab), from Chugai Pharmaceutical (YJ code: 4291476A1028, standard: 1mg 1mL bottle), is a bispecific antibody. It treats relapsed or refractory follicular lymphoma by targeting CD20 on cancer cells and CD3 on T-cells, activating the immune system to destroy cancer cells.
Lunsumio intravenous drip 1mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).